Immutep reports strong response rate from immunotherapies treating carcinomas
Immutep Ltd has reported a slew of positive results from a trial to assess a combination of immunotherapy cancer drugs.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MES | Ann: Removal from Official List | 08/11/12 | 0 | 612 | |||
|
|||||||
MES | Ann: Advice of Cancellation or Shares under Capit | 06/11/12 | 3 | 1.6K | |||
|
|||||||
MES | Ann: Suspension from Official Quotation | 22/10/12 | 0 | 495 | |||
|
|||||||
MES | Ann: Selective Capital Reduction Update | 19/10/12 | 0 | 577 | |||
|
|||||||
MES | Ann: Selective Capital Reduction Funding Update | 09/10/12 | 9 | 2.1K | |||
|
|||||||
MES | Ann: Results of Meetings | 05/10/12 | 0 | 470 | |||
|
|||||||
MES | Ann: Taxation Ruling for Selective Capital Reduct | 24/09/12 | 0 | 373 | |||
|
|||||||
MES | Ann: Notice of Reconvened General Meetings of Mem | 21/09/12 | 2 | 715 | |||
|
See All Discussions